OptimizeRx To Report Q1 2023 Earnings
Company results from the first quarter of 2023 will be reported on the call on May 10.
OptimizeRx's Karina Castagna on New Strategies for the Now Everywhere Point of Care
Read more about Karina's views on eliminating barriers and physician frustration.
OptimizeRx Publishes Second ESG Report
The new report updates our progress on our ESg efforts since the inaugural report published last year.
Financial Times Recognizes OptimizeRx as one of The Americas' Fastest Growing Companies
OptimizeRx was recognized as one of the 500 fastest-growing companies in The Americas for the fourth consecutive year
OptimizeRx Authorizes 15 Million Share Repurchase Program
The Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $15 million of its outstanding common stock.
Multi-year Agreement with Top Hub Services Provider Announced
The patient services provider will license the electronic Hub technology which was introduced to the OptimizeRx suite of solutions through the EvinceMed acquisition in 2022.